Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 235-008-5 | CAS number: 12054-48-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Meets generally accepted scientific standards, well documented and acceptable for publication.
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- publication
- Title:
- Distribution of Various Nickel Compounds in Rat Organs After Oral Administration
- Author:
- ISHlMATSU S, KAWAMOTO T, MATSUNO K, KODAMA Y
- Year:
- 1 995
- Bibliographic source:
- Biological Trace Element Research. 49: 43-52.
Materials and methods
- Objective of study:
- distribution
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- 10 mg NiO in 5% saline was administered to rats by gavage. The rats were sacrificed 24 hr after exposure.
- GLP compliance:
- not specified
Test material
- Reference substance name:
- Nickel monoxide
- EC Number:
- 215-215-7
- EC Name:
- Nickel monoxide
- Cas Number:
- 1313-99-1
- Molecular formula:
- NiO
- IUPAC Name:
- Nickel (II) oxide
- Details on test material:
- - Name of test material (as cited in study report): NiO
- Substance type: green and black
Constituent 1
- Radiolabelling:
- no
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Kyudo Co., Ltd. (Ams., Japan)
- Age at study initiation: 10 wk
- Weight at study initiation: 200 g
- Acclimation period: 2 days
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: 5% saline
- Details on exposure:
VEHICLE
- Justification for use and choice of vehicle (if other than water): increased solubility
- Duration and frequency of treatment / exposure:
- single exposure
Doses / concentrations
- Remarks:
- Doses / Concentrations:
10 mg Ni in NiO
- No. of animals per sex per dose / concentration:
- 8 males
- Control animals:
- yes, concurrent vehicle
- Positive control reference chemical:
- Not applicable.
- Details on study design:
- Not applicable.
- Details on dosing and sampling:
- PHARMACOKINETIC STUDY (Absorption, distribution, excretion)
- Tissues and body fluids sampled (delete / add / specify): urine, blood, lung, liver, kidney, spleen, pacreas, heart, brain
- Time and frequency of sampling: 24 hr
METABOLITE CHARACTERISATION STUDIES
After weighing each organ, it was treated with a mixture of nitric acid and sulfuric acid until completely digested, and the solution was brought to a certain volume with 0.1N nitric acid. Blood samples were used for analysis after being diluted 10 times with 0.1N nitric acid. In addition, 24-h urine was collected by metabolic cage, and each 5 mL of urine was completely digested with nitric acid and brought to a certain volume with 0.1N nitric acid in the same way as the organs. The Ni concentration in the sample solution was determined by a flameless atomic absorption spectrophotometry; the detection limit was 1 ppb.
- Statistics:
- Not reported.
Results and discussion
- Preliminary studies:
- Preliminary data indicated that the soluble Ni compounds were excreted for the most part within 72 h after the oral administration
and the retained amount of Ni in the organ was small. Therefore, the animals were sacrificed 24 h after the administration.
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- In all, 0.01% of green NiO and 0.04% of black NiO was absorbed (based on Ni levels in organs, blood, and urine) at 24 hr.
- Details on distribution in tissues:
- Following exposure to green NiO, the concentration of Ni in organs and blood was not significantly different from control animals. Exposure to black NiO resulted in a significant increase in Ni levels in the lung and kidney.
- Details on excretion:
- Not reported.
Metabolite characterisation studies
- Metabolites identified:
- no
- Details on metabolites:
- only Ni content was measured.
Any other information on results incl. tables
Amount of Nickel 24 hr After Oral Exposure |
|||||
Amount of Ni (ug) |
|||||
Organs | Blood | Urine | Total | AbsorbedFraction, % | |
Green NiO | 0.4 (0.1) | 0.4 (0.1) | 0.2 (0.1) | 0.9 (0.2) | 0.01 |
Black NiO | 1.1 (0.7) | 0.3 (0.1) | 2.6 (1.7) | 4.1 (2.0) | 0.04 |
Date are Mean +/- (SD)
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): low bioaccumulation potential based on study results (oral route of exposure)
The authors concluded that these results suggest that the kinetic behavior of Ni compounds administered orally is closely related with the solubility of Ni compounds, and that the solubility of Ni compounds is one of the important factors for determining the health effect of Ni compounds. - Executive summary:
Ishimatsu et al. (1995) examined the solubility and oral distribution of eight Ni compounds (including green and black NiO) in rats following oral exposure. Solubility of 300 mg of each compound was measured in 50 mL of distilled water or saline. Of the 8 compounds examined, green NiO was the least soluble (~ 1 μg/mL), followed by Ni metal and then black NiO (~ 3.9 - 4.5 μg/mL). For oral exposure, each nickel compound was administered by gavage (10 mg in 5% saline); rats were sacrificed 24 hr after exposure. Following exposure to green NiO, the concentration of Ni in these organs as well as blood was not significantly different from control animals. Exposure to black NiO resulted in a significant increase in Ni levels in the lung and kidney. In all, 0.01 and 0.04% of green and black NiO, respectively, were measurable (absorbed) based on Ni levels in organs, blood, and 24 hr urine. The authors concluded that these results suggest that the kinetic behavior of Ni compounds administered orally is closely related with the solubility of Ni compounds, and that the solubility of Ni compounds is one of the important factors for determining the health effect of Ni compounds (however health effects were not evaluated in this study). Though only one dose was utilized, the findings of this study are useful in demonstrating the potential kinetic differences between green and black NiO. STUDY RATED BY AN INDEPENDENT REVIEWER
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.